Vaxart, Inc. (NASDAQ:VXRT) went up by 13.54% from its latest closing price compared to the recent 1-year high of $17.49. The company’s stock price has collected 49.09% of gains in the last five trading sessions.
Is It Worth Investing in Vaxart, Inc. (NASDAQ :VXRT) Right Now?
Vaxart, Inc. (NASDAQ:VXRT) scored a price-to-earnings ratio above its average ratio, recording x from its present earnings ratio. Plus, the 36-month beta value for VXRT is at 0.06. Opinions of the stock are interesting as 3 analysts out of 3 who provided ratings for Vaxart, Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $19.67, which is -$7.38 below the current price. VXRT currently public float of 108.18M and currently shorts hold a 12.42% ratio of that float. Today, the average trading volume of VXRT was 31.92M shares.
VXRT’s Market Performance
VXRT stocks went up by 49.09% for the week, with a monthly drop of -27.43% and a quarterly performance of 208.79%, while its annual performance rate touched 1035.38%. The volatility ratio for the week stands at 21.22% while the volatility levels for the past 30 days are set at 15.92% for Vaxart, Inc.. The simple moving average for the period of the last 20 days is 13.33% for VXRT stocks with a simple moving average of 95.86% for the last 200 days.
Analysts’ Opinion of VXRT
Many brokerage firms have already submitted their reports for VXRT stocks, with H.C. Wainwright repeating the rating for VXRT by listing it as a “Buy.” The predicted price for VXRT in the upcoming period, according to H.C. Wainwright is $17 based on the research report published on August 12th of the current year 2020.
B. Riley FBR, on the other hand, stated in their research note that they expect to see VXRT reach a price target of $22. The rating they have provided for VXRT stocks is “Buy” according to the report published on July 13th, 2020.
VXRT Trading at -20.62% from the 50-Day Moving Average
After a stumble in the market that brought VXRT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.80% of loss for the given period.
Volatility was left at 15.92%, however, over the last 30 days, the volatility rate increased by 21.22%, as shares sank -22.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.80% lower at present.
During the last 5 trading sessions, VXRT rose by +49.09%, which changed the moving average for the period of 200-days by +2,170.77% in comparison to the 20-day moving average, which settled at $6.41. In addition, Vaxart, Inc. saw 2005.56% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at VXRT starting from ARMISTICE CAPITAL, LLC, who sold 9,385,386 shares at the price of $8.29 back on Jun 29. After this action, ARMISTICE CAPITAL, LLC now owns 145,523 shares of Vaxart, Inc., valued at $77,804,850 using the latest closing price.
ARMISTICE CAPITAL, LLC, the Director of Vaxart, Inc., sold 18,226,667 shares at $10.38 during a trade that took place back on Jun 26, which means that ARMISTICE CAPITAL, LLC is holding 5,440,000 shares at $189,192,803 based on the most recent closing price.
Stock Fundamentals for VXRT
Current profitability levels for the company are sitting at:
- -110.17 for the present operating margin
The net margin for Vaxart, Inc. stands at -189.06. The total capital return value is set at -33.85, while invested capital returns managed to touch -67.27. Equity return is now at value -84.90, with -44.70 for asset returns.
Based on Vaxart, Inc. (VXRT), the company’s capital structure generated 143.95 points at debt to equity in total, while total debt to capital is 59.01. Total debt to assets is 50.35, with long-term debt to equity ratio resting at -4.55. Finally, the long-term debt to capital ratio is 114.95.
When we switch over and look at the enterprise to sales, we see a ratio of 1.29, with the company’s debt to enterprise value settled at 1.47. The receivables turnover for the company is 3.64 and the total asset turnover is 0.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.92.